News for 'diagnostics'

Unfazed by legal blocks, Netmeds bets big on digital

Unfazed by legal blocks, Netmeds bets big on digital

Rediff.com8 Feb 2019

Netmeds is looking at using new technologies such as deep learning and data analytics to improve forecasting in terms of the demand of the products for pharma companies, reports Peerzada Abrar.

Covaxin emergency use decision likely in 4-6 weeks: WHO

Covaxin emergency use decision likely in 4-6 weeks: WHO

Rediff.com10 Jul 2021

There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.

Omicron: Airports ready to implement new health norms

Omicron: Airports ready to implement new health norms

Rediff.com30 Nov 2021

Under the new norms, passengers coming from 12 'at risk' countries/regions undergo an RT-PCR test and wait for result at the airport before leaving or taking a connecting flight

US allows 'game-changer' saliva-based Covid test

US allows 'game-changer' saliva-based Covid test

Rediff.com16 Aug 2020

The new test it will enable rapid testing amongst more people easily.

Omicron: 'Vaccine immunity may be less effective'

Omicron: 'Vaccine immunity may be less effective'

Rediff.com7 Dec 2021

'Antiviral treatment will have no change. Spike protein change may affect the immunity protection.'

Visit A Doc Frequently? Opt For OPD Cover

Visit A Doc Frequently? Opt For OPD Cover

Rediff.com19 Apr 2022

Most traditional health insurance plans didn't cover the cost of such treatments earlier, but several recently launched policies do offer such coverage -- some as a rider, and a few as standalone covers, points out Sarbajeet K Sen.

Found: Doctor-medical centre nexus and Rs 100cr black money

Found: Doctor-medical centre nexus and Rs 100cr black money

Rediff.com2 Dec 2017

It claimed doctors were being paid 'for referring medical tests'.

Have you had your blood tested yet?

Have you had your blood tested yet?

Rediff.com30 Jul 2018

Blood tests are a significant diagnostic method for disease detection, says Prashant Shetty.

India's COVID-19 recovery rate rises to 68.32%

India's COVID-19 recovery rate rises to 68.32%

Rediff.com8 Aug 2020

India has one of the lowest cases per million at 1,469 as against the global average of 2,425, the government said.

Tata Motors launches Nexon EV MAX at Rs 17.74 lakh

Tata Motors launches Nexon EV MAX at Rs 17.74 lakh

Rediff.com11 May 2022

Tata Motors on Wednesday expanded its electric vehicle range in the country with the launch of Nexon EV MAX, priced between Rs 17.74-19.24 lakh (ex-showroom). Equipped with a 40.5 kWh lithium-ion battery pack, the Nexon EV Max offers 33 per cent higher battery capacity than the Nexon EV, delivering ARAI certified range of 437 km (under standard testing conditions), ensuring uninterrupted inter-city travel. ARAI refers to Automotive Research Association of India. The model produces 105 kW (143 PS) of power and delivers a torque of 250 Nm, resulting in 0 to 100 sprint times in under 9 seconds.

Stool sampling among Covid-19 test options before govt

Stool sampling among Covid-19 test options before govt

Rediff.com18 Apr 2020

Private diagnostic laboratories have already approached the respective state governments and the municipalities where they are operating to approve protocols for such testing in clusters, reports Sohini Das.

Sayre Therapeutics: In the business of cancer

Sayre Therapeutics: In the business of cancer

Rediff.com21 Sep 2017

Sayre Therapeutics aims for a spot among top 5 players in oncology.

India to share Co-WIN source software with over 50 countries: R S Sharma

India to share Co-WIN source software with over 50 countries: R S Sharma

Rediff.com28 Jun 2021

About 50 countries, including Canada, Mexico, Nigeria and Panama, have shown interest in having a Co-WIN like system to run their vaccination drive, a senior official said on Monday, adding India is ready to share the open source software free of cost.

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

Rediff.com15 Jul 2020

The Corosure Kit has received ICMR approval with the highest score and DCGI approved with a very high sensitivity and specificity.

How India's healthcare system will change forever

How India's healthcare system will change forever

Rediff.com27 Aug 2020

The National Digital Health Mission seeks to provide a unique health ID to each citizen who wishes to have one and also on-board the healthcare service provides - hospitals, pharmacies and diagnostic labs, among others. It will have an online database of doctors and personal health records.

Rs 40,000 cr approved to deal with Covid: Govt to LS

Rs 40,000 cr approved to deal with Covid: Govt to LS

Rediff.com20 Jul 2021

Rai said as informed by the health ministry, the central government has been providing required technical and financial assistance to all states and Union Territories (UTs) for strengthening their healthcare system, including management of the COVID-19 public health challenge, from time to time, and the financial assistance to states and UTs is provided under the National Health Mission (NHM).

G20 leaders vow to vaccinate 70% world population by mid-2022

G20 leaders vow to vaccinate 70% world population by mid-2022

Rediff.com31 Oct 2021

In the Rome Declaration, the G20 leaders thanked healthcare and frontline workers, international organisations and scientists for their relentless efforts to cope with the deadly COVID-19 pandemic.

COVID-19 test method developed by IIT Delhi gets ICMR nod

COVID-19 test method developed by IIT Delhi gets ICMR nod

Rediff.com23 Apr 2020

IIT Delhi is the first academic institute to have obtained the ICMR approval for a real-time PCR- based diagnostic assay. The development also comes against the backdrop of the Indian Council of Medical Research halting the testing for COVID-19 cases through China-made test kits because of massive variation in test results, compounding the challenge to check and contain the pandemic.

Self-use Covid-19 testing kits to be available at stores for Rs 250

Self-use Covid-19 testing kits to be available at stores for Rs 250

Rediff.com21 May 2021

Pune's Mylab Discovery Solutions' CoviSelf, which gives results in 15 minutes, gets ICMR nod

MF GURU: 'High risk appetite. Where to invest?'

MF GURU: 'High risk appetite. Where to invest?'

Rediff.com10 Oct 2022

Nikunj Saraf, Vice President Choice Wealth, will answers your queries.

COVID-19 test: Why patients opt out of private labs

COVID-19 test: Why patients opt out of private labs

Rediff.com27 Mar 2020

At present, the cost of testing for COVID-19 is Rs 4,500 per examination and the results are available within 24 hours. Almost 90 per cent of queries fizzle out after patients realise the cost of testing will not be borne by the government.

'No preparedness planning, no accountability, no action plan'

'No preparedness planning, no accountability, no action plan'

Rediff.com8 May 2021

'This government did not have any plan for safety stocks of essential medicines.'

Fortis to re-brand itself as Parkway

Fortis to re-brand itself as Parkway

Rediff.com15 Aug 2020

The company said this was 'important' to reinforce the 'complete disassociation' from its erstwhile promoters -- Malvinder and Shivinder Singh.

This super app will offer a range of multi-brand services for passenger cars

This super app will offer a range of multi-brand services for passenger cars

Rediff.com18 Jul 2022

A single application and a plethora of services for passenger cars - that is what myTVS, a brand that operates under Ki Mobility Solutions and is part of the TVS family, is set to bring to customers, in a bid to disrupt the concept of "super apps" in India. Starting July 15, myTVS will launch its connected car platform or super app called myTVS Life360 for aftermarket passenger cars. Through it, customers will be able to avail themselves of a range of services like maintenance, diagnostics, roadside assistance, accessories, payments, insurance, and so on.

Juventus' Rugani, Matuidi recover from COVID-19

Juventus' Rugani, Matuidi recover from COVID-19

Rediff.com16 Apr 2020

The duo were asymptomatic, but the third player, forward Paulo Dybala, showed strong symptoms.

Reliance proposes using tapeworm drug to treat Covid patients

Reliance proposes using tapeworm drug to treat Covid patients

Rediff.com3 Jun 2021

Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.

5 Tech Trends To Watch Out For

5 Tech Trends To Watch Out For

Rediff.com5 Jan 2022

Humans will work far more collaboratively with artificial intelligence for rapid and complex decision-making.

Centre says 25 districts have contained COVID-19 spread

Centre says 25 districts have contained COVID-19 spread

Rediff.com13 Apr 2020

The districts are Gondia (Maharashtra), Raj Nand Gaon (Chhattisgarh), Davangiri (Karnataka), South Goa, Wayanad and Kottayam (Kerala), West Imphal (Manipur), Rajouri (J&K), Aizwal West (Mizoram), Mahe in Puducherry, SBS Nagar in Punjab, Patna, Nalanda and Munger in Bihar, Pratapgarh in Rajasthan, Panipat, Rohtak and Sirsa in Haryana, Pauri Garhwal in Uttrakhand and Bhadradari Kothagudem in Telangana.

How govt plans to buy med devices cheaply for Ayushman

How govt plans to buy med devices cheaply for Ayushman

Rediff.com15 Dec 2019

According to a senior government official, the plan is to do "collective bargaining" for certain medical devices and implants by assuring a bulk requirement to the manufacturers. "The requirement for these devices runs into millions. We assure them that the requirement is going to be in bulk. In return, they should offer us better rates," he said.

Covid cases with variants of concern rose from 10% in May to 51% till June 20

Covid cases with variants of concern rose from 10% in May to 51% till June 20

Rediff.com28 Jun 2021

The panel was informed that the economic impact of the second wave of viral infection was "asynchronous in its onset and wider in its spread particularly in rural hinterland", a source said.

Juve's Dybala recovers from coronavirus

Juve's Dybala recovers from coronavirus

Rediff.com7 May 2020

In March, Dybala confirmed he and his girlfriend, Oriana Sabatini, tested positive for coronavirus.

Omicron: Europe-like surge may mean 1.4 mn cases a day

Omicron: Europe-like surge may mean 1.4 mn cases a day

Rediff.com18 Dec 2021

'We have to ensure the European situation does not occur in India and we don't see a spread like theirs.'

New COVID-19 test can give results in just 45 minutes

New COVID-19 test can give results in just 45 minutes

Rediff.com29 Apr 2020

The test named the "SARS-CoV-2 DETECTR" is easy to implement and to interpret, and requires no specialised equipment, said researchers from the University of California, San Francisco in the US.

4 IPOs to watch out for in 2022

4 IPOs to watch out for in 2022

Rediff.com22 Mar 2022

Once stability returns to the secondary market, companies that have obtained approval from Sebi will start tapping the market.

Tata Motors unveils Tigor EV; sales to begin from Aug 31

Tata Motors unveils Tigor EV; sales to begin from Aug 31

Rediff.com18 Aug 2021

Tata Motors on Wednesday unveiled Tigor EV, its second electric model in the personal mobility space after Nexon EV. The auto major has tasted success with Nexon EV, which currently commands about 70 per cent market share in the domestic electric vehicle segment. The Tigor EV comes powered by the company's high voltage electric architecture - Ziptron - and has been developed based on three pillars of technology, comfort and safety.

ICMR approves TB machines for COVID-19 testing

ICMR approves TB machines for COVID-19 testing

Rediff.com10 Apr 2020

The ICMR has validated 'TruenatTM beta CoV test on TruelabTM workstation' and has recommended it as a screening test,the apex health research body said on Friday.

4.7 mn Covid deaths in India, says WHO; govt objects

4.7 mn Covid deaths in India, says WHO; govt objects

Rediff.com5 May 2022

India has been consistently objecting to the methodology adopted by the WHO to project excess mortality estimates based on mathematical models, the Union Health Ministry said in a statement.

Takeover battle over, Munjal-Burman team bags Fortis

Takeover battle over, Munjal-Burman team bags Fortis

Rediff.com11 May 2018

Their offer values Fortis at over Rs 9,000 crore, or around Rs 172 per share.

India's COVID-19 recovery rate nearing 60%

India's COVID-19 recovery rate nearing 60%

Rediff.com30 Jun 2020

The number of active COVID-19 cases stands at 2,15,125, while 3,34,821 patients have been cured/discharged.

India's COVID-19 toll tops 50,000; over 57K new cases reported

India's COVID-19 toll tops 50,000; over 57K new cases reported

Rediff.com17 Aug 2020

The number of tests for detection of COVID-19 also crossed the three crore-mark in the country, according to the Indian Council of Medical Research (ICMR). The death toll due to COVID-19 climbed to 50,921 with 941 people succumbing to the disease in a span of 24 hours.